Concurrent Use of Opioids and Benzodiazepines
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
This measure evaluates the proportion of people concurrently using prescription opioids and benzodiazepines.
Numerator
The number of member-years of beneficiaries in the denominator with at least 2 prescription claims of a benzodiazepine with unique dates of service and concurrent use of opioids and benzodiazepines during the measurement period.
Denominator
The number of member-years of enrolled beneficiaries, 18 years or older, with at least 2 prescription claims of a prescription opioid with unique dates of service and at least 15 cumulative days supply of opioids during the measurement period.
Exclusions
Contracts with 30 or fewer enrolled member-years (in the denominator), beneficiaries enrolled in hospice, with a cancer diagnosis, with a sickle cell disease diagnosis or receiving palliative care during the measurement year were excluded.
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Prescription Drug Event (PDE) data files submitted to CMS Drug Data Processing System (DDPS), Common Medicare Environment (CME) for enrolment information, the Minimum Data Set (MDS) for nursing home information, the Common Working File (CWF) ICD-10-CM codes to identify diagnoses, the Encounter Data Systems (EDS) used to identify diagnoses based on ICD-10-CM codes, and the PQA Medication Lists, which include the NDCs for this measure.
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reported on www.medicare.gov/plan-compare/